Polymeric microneedles safely and effectively enhanced GHK-Cu skin permeation in in vitro models
Background
The copper peptide GHK-Cu is a well-regarded compound for its role in skin regeneration and wound healing. However, its clinical and cosmetic utility is significantly limited by poor transdermal absorption. GHK-Cu's hydrophilic nature prevents it from efficiently crossing the skin's lipid-rich outer barrier, the stratum corneum. This delivery challenge means that topical applications often fail to deliver a sufficient concentration of the peptide to the deeper skin layers where it exerts its regenerative effects. This study investigates a physical enhancement method to overcome this critical bioavailability hurdle.
Study Design
Researchers used two in vitro skin models, including human and porcine skin, to assess the transdermal delivery of GHK-Cu facilitated by a polymeric microneedle array. The study characterized the microconduits created by the microneedles using histological assay and confocal laser scanning microscopy, correlating penetration depth with varying application forces. Skin permeation of both the GHK peptide and copper was quantified over a 9-hour period. Safety was evaluated by observing signs of skin irritation on cellular and porcine models after microneedle pretreatment and peptide application.
Results
The use of microneedle arrays created a highly effective pathway for GHK-Cu to bypass the skin's primary barrier. The depth of the microconduits was directly correlated with the application force, which in turn dictated the degree of permeation enhancement. While virtually no peptide or copper permeated intact human skin, the microneedle-treated skin showed significant absorption.
Over a 9-hour period, 134 ± 12 nanomoles of the GHK peptide and 705 ± 84 nanomoles of copper successfully permeated through the pre-treated human skin.
Crucially, this enhanced delivery was achieved without compromising safety; cellular and porcine models showed no obvious signs of skin irritation following the procedure. This indicates that the mechanical disruption of the stratum corneum by the microneedles, combined with GHK-Cu application, is a well-tolerated approach.
Key Findings
- Over 9 hours, 134 ± 12 nanomoles of GHK peptide permeated microneedle-treated human skin.
- Over 9 hours, 705 ± 84 nanomoles of copper permeated microneedle-treated human skin.
- Virtually no GHK peptide or copper permeated intact (non-treated) human skin.
- No obvious signs of skin irritation were observed in cellular or porcine models.
- Microneedle penetration depth and subsequent GHK-Cu permeation correlated with application force.
Why It Matters
This study validates a practical method for significantly boosting the topical bioavailability of GHK-Cu, a peptide often limited by poor skin absorption. For users of cosmetic or therapeutic topicals, this suggests that microneedling prior to GHK-Cu application could dramatically increase its effectiveness for skin regeneration and wound healing. This method moves beyond formulation chemistry to a physical delivery enhancement that could be readily adopted. While this research was conducted in vitro, it provides a strong proof-of-concept for human application. The findings also suggest that this microneedle-assisted delivery could be a viable platform for other hydrophilic peptides or minerals, broadening the scope of effective transdermal therapies.
TitrateLab articles covering GHK-Cu
Written by TitrateLab, separately from the study summarized above.
ghk-cu
microneedling
transdermal delivery
skin regeneration
wound healing
in vitro study
